FDA Investigator Leya A Grosch
Leya A Grosch has conducted inspections on 154 sites in 1 countries as of 19 Sep 2014. See below for a list of the FDA enforcement documents resulting from those inspections.
Investigator Details
Number of Inspected Sites:
154
Last Inspection Date:
19 Sep 2014
Investigator Role:
FDA Investigator
Redica ID:
Countries of Inspections:
United States of America
FDA Investigators that have inspected at least one site in common with Leya A Grosch:
Aaron J Poloni,
Abby M Miller,
Abigail A Andersen,
Alan D Grupe,
Alexander M Kay,
Alicia Aborg Borm,
Amber M Howell,
Amy R Glynn,
Andrew S Johnson,
Annette L Diggs,
Avery J Dennis,
Belinda E Clifton,
Brenda K Alford,
Bruce R Burrell,
Bryce E Mansfield,
Ce'nedra M Martin,
Christopher R Czajka,
Christopher S Genther,
Clint R Van Blaricom,
Crystal A Harlan,
Dam S Barkans,
David L Hunsaker,
Dawn E Barkans,
Dennis R Hudson,
Devon M Shoop,
Dirk L Lincoln,
Dolores E Price,
Douglas J Scott,
Elizabeth S Howell,
Eric C Milstead,
Eric L Scott,
Eric S Myskowski,
Erica R Mahone,
Eugene M Abad,
Gordon T Wales,
Hanna L Potter,
Harmon M Blanch,
Heika R Tait,
Hugh A Grimoldby,
Hughes,
Ian J Thomson,
Indigo A Doll,
Isaiah D Isakson,
Jack L Christy,
James D Hildreth,
James E Trabert,
Jane M Kreis,
Jean C Colon Lopez,
Jean R Mccurry,
Jeanne M Weishaar,
Jeannine K Wooten,
Jeff A Gard,
Jeffrey J Leclair,
Jeffrey N Gerdes,
Jessica B Clark,
Jessie J Deloach,
Jinkee Mvila Binayug,
John E Emmert,
John W Banks,
Joie A Riehle,
Jonathan T Little,
Juanj N Wu,
Julia E Chervoni,
Julia Ventura,
Julian C Hanson,
Julie A Stocklin,
Katherine L Arnold,
Kathryn A Krentz,
Kelsey A Hustedt,
Kelsey A Volkman,
Kenneth O Gee, PhD,
Kevin T Gerrity,
Kimberly Jproctor Jones,
Lance W Bohm,
Lauren E Swantko,
LCDR Ismael Olvera, IV,
Leon R Marquart,
Lesley A Swanson,
Lester O Boian,
Lisa A Bowden,
Lori J Jennings,
Lori J Silverstein,
Mai Hang,
Margo C Jones,
Marijo B Kambere, PhD,
Mark E Imsland,
Mark E Moen,
Mark W Babbitt,
Marsha L Mccauley,
Melody S Zeine,
Michael F Schuette,
Michael J Donovan,
Michael J Lackey,
Michael S Hudson,
Misty L Wallace,
Nancy E Byerly,
Nancy E Doyle,
Narahi J Alvarez Alcazar,
Neil J Traaen,
Paul F Rader,
Paul M Kawamoto,
Peter T Regan,
Philip E Ake,
Rachelle M Deskins,
Randy L Elsberry,
Richard A Martin,
Robert A Williams,
Rocco C Black,
Roger J Adams,
Ronald E Gill,
Scott Reynolds,
Scott W Fox,
Shannon J Hall,
Shelagh D Schopen,
Sonia R Peterson,
Stacy A Schneider,
Stephanie A Slater, MS,
Stephanie L Kelly,
Stephen D Weagant,
Sunny R Muir,
Tara A Marshall,
Tara M Pianko,
Thomas C Mclean, CFS,
Timothy D Evans,
Timothy S Williamson,
Vitaliy N Guyvan,
Wayne D Stowell,
William A Burkey,
Willis L Hicks,
Yvonne M Larsen,
Zachary P Wachlarowicz
Experience Redica Systems’ NEW investigator profiles and dashboards
Redica Systems customers get access to over 1,400 FDA Investigator profiles, containing powerful analysis like:
- Total inspections conducted
- 483 rate
- OAI rate
- Warning Letter rate
- Inspections by Industry, Scope, and Inspection Reason
- And much more
Investigator Profiles are not sold as on-demand documents. If you’d like to see one, fill out the form below to connect with our Sales Team and get it in your inbox as little as 24 hours.
![FDA Investigator Profile Icon](/images/InspectorProfile.png)
Talk to sales to access our investigator profiles
Loading...
Investigator Profiles Are Just the Tip of the Iceberg
Becoming a Redica Systems customer not only provides you with unlimited access to profiles similar to the one above for every current and former FDA Investigator, but also grants you access to:
Inspection Intelligence
- Pre-Approval Inspection (PAI) trends
- The ability to filter nearly any FDA enforcement action by GxP labels like GMP, GCP, etc.
- Latest 483s: see what the trends are across all FDA Investigators
- CFR Heatmap: Citations aggregated by Subpart by Year
Vendor Intelligence
- Full inspection histories for your vendors down to the specific site level
- All of the functionality mentioned above but isolated to just your vendors
Regulatory Intelligence
- Zero in on the trends for a specific agency/regulator (ex. FDA, MHRA, EMA, Health Canada)
- All the latest "Signals" from agencies around the world, segmented by Country, Type (ex. Guidance, Decree...), Category (ex. Rules/Regulations/Guidance, News, Reports...), Theme (ex. Cell and Gene Therapy, AI...), and more